U.S. Markets close in 3 hrs 20 mins

PTC Therapeutics to Acquire Agilis Biotherapeutics

Daniel Collins
PTC Therapeutics to Acquire Agilis Biotherapeutics

On July 19, PTC Therapeutics (PTCT) entered into an agreement to acquire Agilis Biotherapeutics. This acquisition is expected to include an upfront payment of $50.0 million in cash and ~$150.0 million in PTC Therapeutics common stock. The acquisition of Agilis Biotherapeutics by PTC Therapeutics is expected to close during the third quarter.